HomeNATCOPHARM • NSE
add
Natco Pharma Ltd
Previous close
₹770.70
Day range
₹776.75 - ₹804.90
Year range
₹757.05 - ₹1,639.00
Market cap
143.02B INR
Avg Volume
1.27M
P/E ratio
7.67
Dividend yield
0.75%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 4.75B | -37.41% |
Operating expense | 4.00B | 7.44% |
Net income | 1.33B | -37.47% |
Net profit margin | 28.01 | -0.11% |
Earnings per share | 7.43 | -37.46% |
EBITDA | 368.00M | -86.02% |
Effective tax rate | 19.12% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.63B | 102.65% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 71.57B | — |
Shares outstanding | 179.00M | — |
Price to book | 1.93 | — |
Return on assets | — | — |
Return on capital | -0.28% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.33B | -37.47% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,016
